Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ).
Jubilant Pharmova Limited has disclosed the transcript of its recent Investors and Analyst Meet, held on February 24, 2025, in compliance with SEBI regulations. This disclosure is part of the company’s ongoing efforts to maintain transparency with its stakeholders and provide insights into its strategic direction and financial performance.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its commitment to innovation and quality in serving the healthcare sector.
YTD Price Performance: -16.49%
Average Trading Volume: 23,459
Current Market Cap: 143.7B INR
For an in-depth examination of JUBLPHARMA stock, go to TipRanks’ Stock Analysis page.